Walleye Trading LLC Kura Oncology, Inc. Transaction History

Walleye Trading LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$17.53 - $22.98 $156,735 - $205,464	-8,941 Reduced 92.29%	747 $15,000
Q1 2024 May 15, 2024	BUY	$13.42 - $23.53 $130,012 - $227,958	9,688 New	9,688 $206,000
Q3 2022 Nov 14, 2022	BUY	$12.01 - $19.45 $398,972 - $646,129	33,220 New	33,220 $454,000
Q4 2018 Feb 14, 2019	SELL	$10.6 - $17.49 $1.01 Million - $1.66 Million	-95,140 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$16.65 - $21.85 $472,676 - $620,299	-28,389 Reduced 22.98%	95,140 $1.67 Million
Q2 2018 Aug 14, 2018	BUY	$14.8 - $18.8 $435,075 - $552,663	29,397 Added 31.23%	123,529 $2.25 Million
Q1 2018 May 15, 2018	BUY	$14.5 - $23.4 $1.36 Million - $2.2 Million	94,132 New	94,132 $1.77 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.